Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VAN DER KWAST, Theo H")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 54

  • Page / 3
Export

Selection :

  • and

Partial laryngectomy for recurrent glottic carcinoma after radiotherapySEWNAIK, Aniel; MEEUWIS, Cees A; VAN DER KWAST, Theo H et al.Head & neck. 2005, Vol 27, Num 2, pp 101-107, issn 1043-3074, 7 p.Article

Defining the window of opportunity in screening for prostate cancer : Validation of a predictivetumor classification modelVIS, André N; HOEDEMAEKER, Robert F; VAN DER KWAST, Theo H et al.The Prostate. 2001, Vol 46, Num 2, pp 154-162, issn 0270-4137Article

Screening for prostate cancer at low PSA range : The impact of digital rectal examination ontumor incidence and tumor characteristicsGOSSELAAR, Claartje; ROOBOL, Monique J; ROEMELING, Stijn et al.The Prostate. 2007, Vol 67, Num 2, pp 154-161, issn 0270-4137, 8 p.Article

Should we replace the gleason score with the amount of high-grade prostate cancer?VIS, André N; ROEMELING, Stijn; KRANSE, Ries et al.European urology. 2007, Vol 51, Num 4, pp 931-939, issn 0302-2838, 9 p.Article

Gleason score, age and screening : Modeling dedifferentiation in prostate cancerDRAISMA, Gerrit; POSTMA, Renske; SCHRÖDER, Fritz H et al.International journal of cancer. 2006, Vol 119, Num 10, pp 2366-2371, issn 0020-7136, 6 p.Article

Gene expression profiling of the human prostate zonesVAN DER HEUL-NIEUWENHUIJSEN, Leonie; HENDRIKSEN, Peter J. M; VAN DER KWAST, Theo H et al.BJU international (Papier). 2006, Vol 98, Num 4, pp 886-897, issn 1464-4096, 12 p.Article

Urine markers for bladder cancer surveillance : A systematic reviewVAN RHIJN, Bas W. G; VAN DER POEL, Henk G; VAN DER KWAST, Theo H et al.European urology. 2005, Vol 47, Num 6, pp 736-748, issn 0302-2838, 13 p.Article

Nomogram use for the prediction of indolent prostate cancer : Impact on screen-detected populationsROEMELING, Stijn; ROOBOL, Monique J; KATTAN, Michael W et al.Cancer. 2007, Vol 110, Num 10, pp 2218-2221, issn 0008-543X, 4 p.Article

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillanceROEMELING, Stijn; ROOBOL, Monique J; POSTMA, Renske et al.European urology. 2006, Vol 50, Num 3, pp 475-482, issn 0302-2838, 8 p.Article

4-year prostate specific antigen progression and diagnosis of prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam. CommentarySCHRÖDER, Fritz H; RAAIJMAKERS, René; POSTMA, Renske et al.The Journal of urology. 2005, Vol 174, Num 2, pp 489-494, issn 0022-5347, 6 p.Article

The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancerVIS, Andre N; HOEDEMAEKER, Robert F; ROOBOL, Monique et al.Cancer. 2001, Vol 92, Num 3, pp 524-534, issn 0008-543XArticle

Detection of prostate cancer : A comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsyVIS, André N; BOERMA, Michiel O; CIATTO, Stefano et al.Urology (Ridgewood, NJ). 2000, Vol 56, Num 4, pp 617-621, issn 0090-4295Article

Does PSA velocity predict prostate cancer in pre-screened populations? CommentarySCHRÖDER, Fritz H; ROOBOL, Monique J; VAN DER KWAST, Theo H et al.European urology. 2006, Vol 49, Num 3, pp 460-465, issn 0302-2838, 6 p.Article

Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 yearsPOSTMA, Rensbe; DE VRIES, Shijn H; ROOBOL, Monique J et al.Cancer. 2005, Vol 103, Num 4, pp 708-716, issn 0008-543X, 9 p.Article

Metastatic disease of screen-detected prostate cancer : Characteristics at diagnosisROEMELING, Stijn; KRANSE, Ries; VIS, André N et al.Cancer. 2006, Vol 107, Num 12, pp 2779-2785, issn 0008-543X, 7 p.Article

Frequent FGFR3 mutations in urothelial papillomaVAN RHIJN, Bas W. G; MONTIRONI, Rodolfo; ZWARTHOFF, Ellen C et al.Journal of pathology. 2002, Vol 198, Num 2, pp 245-251, issn 0022-3417Article

Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screeningtest at low PSA (0.0-3.9 ng/ml)VIS, André N; HOEDEMAEKER, Robert F; ROOBOL, Monique et al.The Prostate. 2001, Vol 47, Num 4, pp 252-261, issn 0270-4137Article

Prognostic value of cell cycle proteins p27kip1 and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancerVIS, André N; NOORDZIJ, Marinus A; FITOZ, Kubilay et al.The Journal of urology. 2000, Vol 164, Num 6, pp 2156-2161, issn 0022-5347Article

Cytology and Urinary Markers for the Diagnosis of Bladder CancerVAN RHIJN, Bas W. G; VAN DER POEL, Henk G; VAN DER KWAST, Theo H et al.European urology. Supplement. 2009, Vol 8, Num 7, pp 536-541, issn 1569-9056, 6 p.Article

Le récepteur de type 3 des FGF (FGFR3): de la chondrodysplasie… au cancer de la vessie = Fibroblast growth factor receptor: from chondrodysplasia to bladder cancerRADVANYI, Francois; THIERY, Jean-Paul; BILLEREY, Claude et al.MS. Médecine sciences. 2001, Vol 17, Num 11, pp 1189-1191, issn 0767-0974Article

Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened populationROEMELING, Stijn; ROOBOL, Monique J; DE VRIES, Stijn H et al.The Journal of urology. 2006, Vol 175, Num 4, pp 1332-1336, issn 0022-5347, 5 p.Conference Paper

Molecular evolution of multiple recurrent cancers of the bladderVAN TILBORG, Angela A. G; DE VRIES, Annie; DE BONT, Maarten et al.Human molecular genetics (Print). 2000, Vol 9, Num 20, pp 2973-2980, issn 0964-6906Article

Array-based genomic analysis of screen-detected gleason score 6 and 7 prostatic adenocarcinomasPOSTMA, Renske; VAN MARION, Ronald; VAN DUIN, Mark et al.Anticancer research. 2006, Vol 26, Num 2A, pp 1193-1200, issn 0250-7005, 8 p.Article

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancerFOEKENS, John A; PETERS, Harry A; GREBENCHTCHIKOV, Nicolai et al.Cancer research (Baltimore). 2001, Vol 61, Num 14, pp 5407-5414, issn 0008-5472Article

Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urineVAN RHIJN, Bas W. G; LURKIN, Irene; CHOPIN, Dominique K et al.Clinical cancer research. 2003, Vol 9, Num 1, pp 257-263, issn 1078-0432, 7 p.Article

  • Page / 3